Home›Companies›Healthcare›Amptiv Biosciences

Amptiv Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 4, 2025·Suggest an edit

About Amptiv Biosciences

Amptiv Biosciences is a private company based in Cleveland, Ohio, incorporated in 2024 in Delaware. It has reported $500,000 raised in two offerings on Form D since December 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 21, 2025Apr 4, 2025$300,000of $1.3M target3$100KOptionsRule 506(b)Form D ↗
Dec 18, 2024Dec 31, 2024$200,000fully sold1$200KOptionsRule 506(b)Form D ↗
Total, two offerings$500,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amptiv Biosciences's Form D filed Apr 4, 2025.

JA
JB
Jonathan Bell
President and director

Sources

  1. SECAmptiv Biosciences, Inc. filing history